rawfin.tv
Foundation Medicine, Bristol Myers Squibb Expand Diagnostic Collaboration
TechnologystocksAI Generated

Foundation Medicine, Bristol Myers Squibb Expand Diagnostic Collaboration

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Foundation Medicine announced an expanded collaboration with Bristol Myers Squibb to develop a next-generation sequencing companion diagnostic. The partnership aims to identify patients with homozygous MTAP deletion, advancing precision medicine.

BiotechPharmaceuticalsCollaborationDiagnostics

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks